rs190968346
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001206744.2(TPO):c.2647C>T(p.Pro883Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000198 in 1,613,636 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001206744.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPO | NM_001206744.2 | c.2647C>T | p.Pro883Ser | missense_variant | 16/17 | ENST00000329066.9 | NP_001193673.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPO | ENST00000329066.9 | c.2647C>T | p.Pro883Ser | missense_variant | 16/17 | 1 | NM_001206744.2 | ENSP00000329869.4 |
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152192Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000446 AC: 112AN: 251000Hom.: 0 AF XY: 0.000302 AC XY: 41AN XY: 135804
GnomAD4 exome AF: 0.000196 AC: 286AN: 1461326Hom.: 2 Cov.: 31 AF XY: 0.000169 AC XY: 123AN XY: 726958
GnomAD4 genome AF: 0.000223 AC: 34AN: 152310Hom.: 0 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74472
ClinVar
Submissions by phenotype
Deficiency of iodide peroxidase Pathogenic:1Uncertain:2
Uncertain significance, criteria provided, single submitter | reference population | Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center | Mar 18, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | 3billion | Jul 30, 2024 | The variant is observed at an extremely low frequency in the gnomAD v4.0.0 dataset (total allele frequency: 0.020%). In silico tool predictions suggest no damaging effect of the variant on gene or gene product [REVEL: 0.32 (<0.4); 3Cnet: 0.01 (<0.15)]. A different missense change at the same codon (p.Pro883Arg) has been reported to be associated with TPO-related disorder (PMID: 31430255). Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Juno Genomics, Hangzhou Juno Genomics, Inc | - | PM3+PP4+PP1_Strong - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 12, 2024 | Variant summary: TPO c.2647C>T (p.Pro883Ser) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00045 in 251000 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in TPO causing Deficiency Of Iodide Peroxidase (0.00045 vs 0.0071), allowing no conclusion about variant significance (gnomAD v2). It is hower found in two homozygotes in gnomAD v4. c.2647C>T has been reported in the literature in individuals affected with congenital hypothyroidism: in one case, it was evaluated as Likely Benign per the ACMG criteria, and in another caes, this variant was at a homozygous state co-ocurring with other homozygous pathogenic variant (TPO c.1618C>T, p.R540*). Such reports provide supporting evidence for a benign role (Umeki_2004, Wang_2020). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 15055360, 32319661). ClinVar contains an entry for this variant (Variation ID: 225496). Based on the evidence outlined above, the variant was classified as likely benign. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at